Issue 0, 1985

Triazines and related products. Part 30. Cationic analogues of the antitumour drug 2,4,6-tris(dimethylamino)-1,3,5-triazine (hexamethylmelamine)

Abstract

Chloro-1,3,5-triazines react with trimethylamine in ether to afford water-soluble quaternary salts. 2,4,6-Tris(dimethylamino)-1,3,5-oxadiazinium chloride (10) is formed when dimethylcyanamide and dimethylcarbamoyl chloride are heated at 170 °C. The oxadiazinium chloride reacts with ammonia to afford 2,4-bis(dimethylamino)-1,3,5-triazin-6(1H)-one by an ANRORC reaction, with primary amines to afford amine-adducts (15) of the 1,3,5-oxadiazine or, under forcing conditions, 1,2,4-trisubstituted-1,3,5-triazin-6(1H)-ones (20), (21) or (22). None of the cationic salts displayed antitumour activity in vivo in tumour-bearing mice and they were poor substrates for oxidative metabolism in vitro.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 1, 1985, 1533-1539

Triazines and related products. Part 30. Cationic analogues of the antitumour drug 2,4,6-tris(dimethylamino)-1,3,5-triazine (hexamethylmelamine)

P. Rushton and M. F. G. Stevens, J. Chem. Soc., Perkin Trans. 1, 1985, 1533 DOI: 10.1039/P19850001533

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements